Download PDF
Deutsche Zeitschrift für Onkologie 2019; 51(03): 145-147
DOI: 10.1055/a-0977-6811
Forum – GfBK kommentiert
© Georg Thieme Verlag KG Stuttgart · New York

ASS und Kopf-Hals-Tumore

Further Information

Publication History

Publication Date:
26 September 2019 (online)

    Permissions and Reprints

Hedberg ML, Peyser ND, Bauman JE et al. Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer. J Exp Med 2019; 216: 419–427. doi:10.1084/jem.20181936

 

  • Literatur

  • 1 Hua X, Phipps AI, Burnett-Hartman AN. et al. Timing of Aspirin and other nonsteroidal anti-inflammatory drug use among patients with colorectal cancer in relation to tumor markers and survival. J Clin Oncol 2017; 35: 2806-2813
    CrossrefPubMedGoogle Scholar
  • 2 Hamada T, Cao Y, Qian ZR. et al. Aspirin use and colorectal cancer survival according to tumor CD274 (programmed cell death 1 ligand 1) expression status. J Clin Oncol 2017; 35: 1836-1844
    CrossrefPubMedGoogle Scholar
  • 3 Neugut AI. Aspirin as adjuvant therapy for stage III colon cancer: standard of care? JAMA. Intern Med 2014; 174: 739-741
    PubMedGoogle Scholar
  • 4 Cuzick J, Thorat MA, Bosetti C. et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Annals of Oncology 2015; 26: 47-57
    CrossrefPubMedGoogle Scholar
  • 5 Kujundžić RN, Stepanić V, Milković L. et al. Curcumin and its potential for systemic targeting of inflamm-aging and metabolic reprogramming in cancer. Int J Mol Sci 2019; 20 DOI: 10.3390/ijms20051180.
    CrossrefPubMedGoogle Scholar
  • 6 Mayor S. Eating more fibre linked to reduced risk of non-communicable diseases and death. BMJ 2019; 364: l159 doi:10.1136/bmj.l159
    PubMedGoogle Scholar
  • 7 Viaud S, Saccheri F, Mignot G. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013; 342: 971-976
    CrossrefPubMedGoogle Scholar
  • 8 Iida N, Dzutsev A, Stewart CA. et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 2013; 342: 967-970
    CrossrefPubMedGoogle Scholar
  • 9 Singh P, Kumar M, Al Khodor S. Vitamin D deficiency in the Gulf Cooperation Council: exploring the triad of genetic predisposition, the gut microbiome and the immune system. Front Immunol 2019; 10: 1042
    CrossrefPubMedGoogle Scholar
  • 10 Waterhouse M, Hope B, Krause L. et al. Vitamin D and the gut microbiome: a systematic review of in vivo studies. Eur J Nutr 2018; DOI: 10.1007/s00394-018-1842-7. [Epub ahead of print]
    CrossrefPubMedGoogle Scholar
  • 11 Lo PK, Yao Y, Lee JS. et al. LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer. eLife 2018; 7 doi:10.7554/eLife.31334
    PubMedGoogle Scholar
  • 12 Chlebowski RT, Aragaki AK, Anderson GL. et al. Association of low-fat dietary pattern with breast cancer overall survival: a secondary analysis of the Women's Health Initiative Randomized Clinical Trial. JAMA Oncol 2018; 4: e181212
    CrossrefPubMedGoogle Scholar
  • 13 Maas M, Beets-Tan RG, Lambregts DM. et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011; 29: 4633-4640
    CrossrefPubMedGoogle Scholar
  • 14 Renehan AG, Malcomson L, Emsley R. et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol 2016; 17: 174-183
    CrossrefPubMedGoogle Scholar